{"nctId":"NCT02592824","briefTitle":"Glutamate for Metabolic Intervention in Coronary Surgery II","startDateStruct":{"date":"2015-11-15","type":"ACTUAL"},"conditions":["Coronary Artery Bypass Surgery","Postoperative Complications","Heart Failure"],"count":321,"armGroups":[{"label":"Intravenous glutamate infusion","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: glutamate infusion"]},{"label":"Intravenous saline infusion","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: saline infusion"]}],"interventions":[{"name":"glutamate infusion","otherNames":["glutamate"]},{"name":"saline infusion","otherNames":["saline"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\nPatients accepted for coronary artery bypass surgery of at least two vessel disease or left main stenosis with or without concomitant procedure considered to be at moderate to high surgical risk preoperatively with regard to postoperative heart failure due to:\n\n• EuroSCORE II ≥ 3.0 with at least one of the following cardiac or procedure related risk factors:\n\n* LVEF ≤ 0.50\n* CCS class IV\n* Recent Myocardial Infarct (≤ 90 days)\n* Emergency / Urgent procedure (as defined in EuroSCORE II)\n* CABG with aortic or mitral valve procedure\n\nOR\n\n• LVEF ≤ 0.30 regardless of EuroSCORE II\n\nExclusion Criteria:\n\n* age \\> 85 years\n* ambiguous food allergies that trigger shortness of breath, headache or flushing\n* previous cardiac surgery\n* patients who are in such bad condition that they cannot be asked to participate\n* patients who because of linguistic or other reasons are unable to provide informed consent\n* severe renal failure with preoperative dialysis or calculated GFR \\<30 mL / min\n* patients requiring mechanical circulatory support (intra-aortic balloon pump) due to circulatory failure before they are enrolled in the study\n* surgery without heart-lung machine (off-pump)\n* concomitant Maze-procedure\n* surgery of ascending aorta\n* surgery of both aortic and mitral valve","healthyVolunteers":false,"sex":"ALL","minimumAge":"20 Years","maximumAge":"85 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Postoperative Increase of Plasma NT-proBNP","description":"Postoperative increase of NT-proBNP reflects postoperative myocardial dysfunction sustained in association with surgery. NT-proBNP usually peaks on the third to fourth postoperative day after coronary artery bypass surgery.\n\nIn the first GLUTAMICS trial a good agreement between hemodynamic criteria for postoperative heart failure and postoperative NT-proBNP was found.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5390","spread":"5396"},{"groupId":"OG001","value":"6452","spread":"5215"}]}]}]},{"type":"SECONDARY","title":"Postoperative Plasma Level of NT-proBNP","description":"Postoperative NT-proBNP reflects postoperative myocardial dysfunction.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4438","spread":"4879"},{"groupId":"OG001","value":"4420","spread":"4236"}]}]}]},{"type":"SECONDARY","title":"Postoperative Plasma Level of NT-proBNP","description":"Postoperative NT-proBNP reflects postoperative myocardial dysfunction.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"8055","spread":"7546"},{"groupId":"OG001","value":"8804","spread":"6606"}]}]}]},{"type":"SECONDARY","title":"Number of Participants With Incidence of Stroke","description":"Postoperative stroke was defined as neurological or cognitive deficit with a cerebral injury verified on (Computed Tomography) CT-scan. All suspected cases of stroke underwent CT-scan.\n\nStroke within 24 h of surgery was defined as a stroke that occurred within 24 h of surgery or signs of a stroke, when first assessable in deeply sedated patients on a ventilator.","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"4","spread":null}]}]}]},{"type":"SECONDARY","title":"Incidence of Mortality","description":"Postoperative mortality was defined as mortality within 30 days of surgery.","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"6","spread":null}]}]}]},{"type":"SECONDARY","title":"Incidence of Unexpected Adverse Events","description":"suspected unexpected serious adverse reaction","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]}]},{"type":"OTHER_PRE_SPECIFIED","title":"Copeptin Substudy","description":"Exploratory assessment of plasma-Copeptin related to NT-proBNP","paramType":null,"dispersionType":null,"classes":[]},{"type":"POST_HOC","title":"Postoperative Increase of Plasma NT-proBNP in Patients Without Diabetes","description":"Postoperative increase of NT-proBNP reflects postoperative myocardial dysfunction sustained in association with surgery. NT-proBNP usually peaks on the third to fourth postoperative day after coronary artery bypass surgery.\n\nPrevious observations suggest a blunted effect of glutamate in diabetic hearts.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4503","spread":"4846"},{"groupId":"OG001","value":"6825","spread":"5671"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":65,"n":148},"commonTop":["Postoperative Atrial fibrillation"]}}}